The subtype with the worst prognosis is triple negative breast cancer [TNBC; estrogen receptors-/progesterone receptors-/human epidermal growth factor receptor 2 (HER2)-], due to its high probability to metastasize and the lack of a specific target for its treatment [4]. The gene discussed is ERBB2; the disease is triple-negative breast carcinoma.